A chronic inflammatory disease is a condition characterized by persistent inflammation. A number of human pathologies fall into this category, and a great deal of research has been conducted to learn more about their characteristics and underlying mechanisms. In many cases, a genetic component has been identified, but also external factors like food, smoke, or environmental pollutants can significantly contribute to worsen their symptoms. Accumulated evidence clearly shows that chronic inflammatory diseases are subjected to a redox control. Here, we shall review the identity, source, regulation, and biological activity of redox molecules, to put in a better perspective their key-role in cancer, diabetes, cardiovascular diseases, atherosclerosis, chronic obstructive pulmonary diseases, and inflammatory bowel diseases. In addition, the impact of redox species on autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus, psoriasis, and celiac disease) and neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis) will be discussed, along with their potential therapeutic implications as novel drugs to combat chronic inflammatory disorders. Antioxid. Redox Signal. 15, 2605–2641.
AmesBN, CathcartR, SchwiersE, HochsteinP. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA, 78:6858–6862. 1981.
6.
AnderssonAK, LiC, BrennanFM. Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther, 10:204. 2008.
7.
AntunesF, SalvadorA, MarinhoHS, AlvesR, PintoRE. Lipid peroxidation in mitochondrial inner membranes. I. An integrative kinetic model. Free Radic Biol Med, 21:917–943. 1996.
8.
ArnérE, HolmgrenA. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 267:6102–6109. 2000.
9.
BaasAS, BerkBC. Differential activation of mitogen-activated protein kinases by H2O2 and O22 in vascular smooth muscle cells. Circ Res, 77:29–36. 1995.
BaeYS, SungJY, KimOS, KimYJ, HurKC, KazlauskasA, RheeSG. Platelet-derived growth factor-induced H2O2 production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem, 275:10527–10531. 2000.
12.
BarajasB, CheN, YinF, RowshanradA, OrozcoLD, GongKW, WangX, CastellaniLW, ReueK, LusisAJ, AraujoJA. NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arterioscler Thromb Vasc Biol, 31:58–66. 2010.
13.
BarrettWC, DegnoreJP, KengYF, ZhangZY, YimMB, ChockPB. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J Biol Chem, 274:34543–34546. 1999.
14.
BashanN, KovsanJ, KachkoI, OvadiaH, RudichA. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev, 89:27–71. 2009.
15.
BatthyanyC, SchopferFJ, BakerPR, DuranR, BakerLM, HuangY, CervenanskyC, BranchaudBP, FreemanBA. Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J Biol Chem, 281:20450–20463. 2006.
16.
BaynesJW. Role of oxidative stress in development of complications in diabetes. Diabetes, 40:405–412. 1991.
17.
BealMF. Does impairment of energy metabolism results in excitotoxic neuronal death in neurodegenerative illnesses. Ann Neurol, 31:119–130. 1992.
18.
BeckerC, Bray-FrenchK, DreweJ. Pharmacokinetic evaluation of idebenone. Expert Opin Drug Metab Toxicol, 6:1437–1444. 2010.
19.
BeltowskiJ, WojcickaG, Jamroz-WisniewskaA. Adverse Effects of Statins–Mechanisms and Consequences. Curr Drug Saf, 4:209–228. 2009.
20.
Ben MansourR, LassouedS, ElgaiedA, HaddoukS, MarzoukS, BahloulZ, MasmoudiH, AttiaH, AïfaMS, FakhfakhF. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol, 39:247–253. 2010.
21.
BennettPH. The diagnosis of diabetes: New internal classification and diagnostic criteria. Annu Rev Med, 34:295. 1983.
22.
BergamoP, MauranoF, D'ArienzoR, DavidC, RossiM. Association between activation of phase 2 enzymes and down-regulation of dendritic cell maturation by c9,t11-conjugated linoleic acid. Immunol Lett, 117:181–190. 2008.
23.
BermanSB, HastingsTG. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem, 73:1127–1137. 1999.
24.
BiswasSK, McClureD, JimenezLA, MegsonIL, RahmanI. Curcumin induces glutathione biosynthesis and inhibits NF-kB activation and interleukin-8 releae in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal, 7:32–41. 2005.
25.
BlindauerCA, LeszczyszynOI. Metallothioneins: unparalleled diversity in structures and functions for metal ion homeostasis and more. Nat Prod Rep, 27:720–741. 2010.
26.
BöL, DawsonTM, WesselinghS, MörkS, ChoiS, KongPA, HanleyD, TrappBD. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol, 36:778–786. 1994.
27.
BogdanC. Nitric oxide and the immune response. Nat Immunol, 2:907–916. 2001.
28.
BonettiPO, LermanLO, LermanA. Endothelial dysfunction: A marker for atherosclerotic risk. Arterioscler Thromb Vasc Biol, 23:168–175. 2003.
29.
BoniniMG, AugustoO. Carbon dioxide stimulates the production of thiyl, sulfinyl, and disulfide radical anion from thiol oxidation by peroxynitrite. J Biol Chem, 276:9749–9754. 2000.
30.
BourdonE, BlacheD. The importance of proteins in defense against oxidation. Antioxid Redox Signal, 3:293–311. 2001.
31.
BowlerRP, ShengH, EnghildJJ, PearlsteinRD, WarnerDS, CrapoJD. A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. Free Radic Biol Med, 33:1141–1152. 2002.
BushAI, TanziRE. Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics, 5:421–432. 2008.
40.
CarterBJ, AnklesariaP, ChoiS, EngelhardtJF. Redox modifier genes and pathways in amyotrophic lateral sclerosis. Antioxid Redox Signal., 11:1569–1586. 2009.
41.
CastelloPR, DrechselDA, PatelM. Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J Biol Chem, 282:14186–14193. 2007.
42.
CeaserEK, MoelleringDR, ShivaS, RamachandranA, LandarA, VenkartramanA, CrawfordJ, PatelR, DickinsonDA, UlasovaE, JiS, Darley-UsmarVM. Mechanisms of Signal Transduction mediated by Oxidized Lipids: the Role of the Electrophile-responsive Proteome. Biochem Soc Trans, 32:151–155. 2004.
43.
Cernuda-MorollónE, Pineda-MolinaE, CañadaFJ, Pérez-SalaD. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J Biol Chem, 276:35530–35536. 2001.
ChaudièreJ, Ferrari-IliouR. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol, 37:949–962. 1999.
46.
ChelikaniP, FitaI, LoewenPC. Diversity of structures and properties among catalases. Cell Mol Life Sci, 61:192–208. 2004.
47.
ChoJH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol, 8:458–466. 2008.
48.
ClaiborneA, YehJI, MallettTC, LubaJ, CraneEJIII, CharrierV, ParsonageD. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry, 38:15407–15416. 1999.
49.
CooperCE, LynaghGR, HoyesKP, HiderRC, CammackR, PorterJB. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide Reductase. J Biol Chem, 271:20291–20299. 1996.
50.
CooperRL. Multiple sclerosis: an immune legacy?Med Hypotheses, 49:307–311. 1997.
51.
CostenbaderKH, KangJH, KarlsonEW. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol, 172:205–216. 2010.
CrawfordDR, ZbindenI, AmstadP, CeruttiP. Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermal cells. Oncogene, 3:27–32. 1988.
55.
CrowJP, CalingasanNY, ChenJ, HillJL, BealMF. Manganese porphyrin given at symptom onset markedly extends survival of ALS mice. Ann Neurol, 58:258–265. 2005.
56.
CulottaE, KoshlandDEJr. NO news is good news (nitric oxide; includes information about other significant advances & discoveries of 1992) (molecule of the year)Science, 258:1862–1864. 1992.
57.
CzechMP, LawrenceJCJR, LynnWS. Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci USA, 71:4173–4177. 1974.
58.
DaineseE, AngelucciCB, SabatucciA, De FilippisV, MeiG, MaccarroneM. A novel role for iron in modulating the activity and membrane binding ability of a trimmed soybean lipoxygenase-1. FASEB J, 24:1725–1736. 2010.
59.
DattaR, HallahanDE, KharbandaSM, RubinE, ShermanML, HubermanE, WeichselbaumRR, KufeDW. Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation. Biochemistry, 31:8300–8306. 1992.
60.
De StefanoN, NaroyoananS, MatthewsPM, FrancisGS, AntelJP, ArnoldDL. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain, 122:1933–1939. 1999.
61.
Di BonaD, ScapagniniG, CandoreG, CastigliaL, Colonna-RomanoG, DuroG, NuzzoD, IemoloF, LioD, PellicanòM, ScafidiV, CarusoC, VastoS. Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications. Curr Pharm Des, 16:684–691. 2010.
62.
DibM. Amyotrophic lateral sclerosis: progress and prospects for treatment. Drugs, 63:289–310. 2003.
DoraiswamyPM, FinefrockAE. Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol, 3:431–434. 2004.
65.
DoyleMP, HoekstraJW. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem, 14:351–358. 1981.
66.
DrogeW. Free radicals in the physiological control of cell function. Physiol Rev, 82:47–95. 2002.
67.
EggR, ReindlM, DeisenhammerF, LiningtonC, BergerT. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Mult Scler, 5:285–289. 2001.
68.
EllisL, AtadjaPW, JohnstoneRW. Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther, 8:1409–1420. 2009.
69.
EnglandK, CotterTG. Direct oxidative modifications of signaling proteins in mammalian cells and their effects on apoptosis. Redox Rep, 10:237–245. 2005.
70.
EspeyMG, ThomasDD, MirandaKM, WinkDA. Protein nitration is mediated by heme and free metals through fenton-type chemistry: an alternative to the NO/O2-reaction. Proc Nat Acad Sci USA, 99:12691–12696. 2002.
FinleyJW, WheelerEL, WittSC. Oxidation of glutathione by hydrogen peroxide and other oxidizing agents. J Agric Food Chem, 29:404–407. 1981.
74.
FlierJS, UnderhillLH. Caloric intake and aging. N Engl J Med, 337:986–994. 1997.
75.
FrankB, GuptaS. A review of antioxidants and Alzheimer's disease. Ann Clin Psychiatry, 17:269–286. 2005.
76.
GalterD, MihmS, DrogeW. Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. Eur J Biochem, 221:639–648. 1994.
77.
GardnerPR, FridovichI. Superoxide sensitivity of the escherichia coli aconitase. J Biol Chem, 266:19328–19333. 1991.
78.
GarthwaiteJ, BoultonCL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol, 57:683–706. 1995.
79.
GeldermanKA, HultqvistM, OlssonLM, BauerK, PizzollaA, OlofssonP, HolmdahlR. Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. Antioxid Redox Signal, 9:1541–1567. 2007.
80.
GeorgeJL, MokS, MosesD, WilkinsS, BushAI, ChernyRA, FinkelsteinDI. Targeting the progression of Parkinson's disease. Curr Neuropharmacol, 7:9–36. 2009.
81.
GhadgeGD, LeeJP, BindokasVP, JordanJ, MaL, MillerRJ, RoosRP. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neurosci, 17:8756–8766. 1997.
82.
GhezziP. Review: regulation of protein function by glutathionylation. Free Radic Res, 39:573–580. 2005.
83.
GilesGI, TaskerKM, JacobC. Hypothesis: The role of reactive sulphur species in oxidative stress. Free Radic Biol Med, 31:1279–1283. 2001.
84.
Gilgun-SherkiY, MelamedE, OffenD. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology, 40:959–975. 2001.
85.
Gilgun-SherkiY, MelamedE, OffenD. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol, 251:261–268. 2004.
86.
GolbeLI, FarrelTLM, DavisPH. Case control study of early life dietary factors in Parkinson's disease. Arch Neurol, 45:1350–1353. 1988.
87.
GopalarishnaR, AndersonWB. Ca2+ and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA, 86:6758–6762. 1989.
88.
GrandjeanEM, BerthetP, RuffmannR, LeuenbergerP. Efficacy and oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther, 22:209–221. 2000.
89.
GrassiD, DesideriG, FerriC. Flavonoids: antioxidants against atherosclerosis. Nutrients, 2:889–902. 2010.
90.
GreavesDR, GordonS. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J Lipid Res, 50:282–286. 2009.
91.
GreenacreSA, IschiropoulosH. Tyrosine nitration: localization, quantification, consequences for protein function and signal transduction. Free Radic Res, 34:541–581. 2001.
92.
GribkoffVK, BozikME. KNS-760704 [(6R)-4,5,6,7-Tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis. CNS Neurosci Ther, 14:215–226. 2008.
93.
HackV, SchmidD, BreitkreutzR, Stahal-HennigC, DringsP, KinscherfR, TautF, HolmE, DrogeW. Cystine levels, cystine flux and protein catabolism in cancer cachexia, HIV/SIV infection and senescence. FASEB J, 11:84–92. 1997.
94.
HaddadJJ. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal, 14:879–897. 2002.
95.
HallED. Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders. Ann Neurol, 32:S137–S142. 1992.
96.
HallED, AndrusPK, OostreenJA, FleckTJ, GurneyME. Relationship of oxygen radial-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res, 53:66–77. 1998.
97.
HalliwellB, GutteridgeJM. The antioxidants of human extracellular fluids. Arch Biochem Biophys, 280:1–8. 1990.
98.
HalliwellB, GutteridgeJM. Free radicals in Biology and Medicine, 3rd. Oxford: Oxford University Press, 1999.
99.
HalliwellB, GutteridgeJM. Free Radical in Biology and Medicine, 2nd. Oxford: Oxford University Press, 1989.
100.
HandCE, HonekJF. Biological chemistry of naturally occurring thiols of microbial and marine origin. J Nat Prod, 68:293–308. 2005.
101.
HarborneJB, WilliamsCA. The flavonoids: advances in research since 1992. Phytochemistry, 55:481–504. 2000.
102.
HardwickJS, SeftonBM. Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. Proc Natl Acad Sci USA, 92:4527–4531. 1995.
103.
HarleyCB, FutcherAB, GreiderCW. Telomeres shorten during ageing of human fibroblasts. Nature, 345:458–460. 1990.
104.
HarmanD. Aging: a theory based on free radical and radiation chemistry. J Gerontol, 11:298–300. 1956.
105.
HatcherH, PlanalpR, ChoJ, TortiFM, TortiSV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci, 65:1631–1652. 2008.
106.
HayashiT, UeonoY, OkamotoT. Oxidoreductive regulation of nuclear factor kB. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem, 268:11380–11388. 1993.
HiguchiM, IshizuA, IkedaH, HayaseH, FugoK, TsujiM, AbeA, SugayaT, SuzukiA, TakahashiT, KoikeT, YoshikiT. Functional alteration of peripheral CD25(+)CD4(+) immunoregulatory T cells in a transgenic rat model of autoimmune diseases. J Autoimmun, 20:43–49. 2003.
112.
HoggJC, ChuF, UtokaparchS, WoodsR, ElliotWM, ButazuL, CherniackRM, RogersRM, SciurbaFC, CoxsonHO, ParéPD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med, 350:2645–2653. 2004.
113.
HokariR, MiuraS, FujimoriH, TsuzukiY, ShigematsuT, HiguchiH, KimuraH, KuroseI, SerizawaH, SuematsuM, YagitaH, GrangerDN, IshiiH. Nitric oxide modulates T-lymphocyte migration in Peyer's patches and villous submucosa of rat small intestine. Gastroenterology, 115:618–627. 1998.
114.
HooperDC, BagasraO, MariniJC, ZborekA, OhnishiST, KeanR, ChampionJM, SarkerAB, BobroskiL, FarberJL, AkaikeT, MaedaH, KoprowskiH. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA, 94:2528–2533. 1997.
115.
HutterC. On the causes of multiple sclerosis. Med Hypotheses, 41:93–96. 1993.
116.
IchimiyaM, ChangSH, LiuH, BerezeskyIK, TrumpBF, AmstadPA. Effect of Bcl-2 on oxidant-induced cell death and intracellular Ca2+ mobilization. Am J Physiol, 275:C832–C839. 1998.
IsomAL, BarnesS, WilsonL, KirkM, CowardL, Darley-UsmarV. Modification of cytochrome c by 4-hydroxy-2-nonenal: evidence for histidine, lysine, and arginine-aldehyde adducts. J Am Soc Mass Spectrom, 15:1136–1147. 2004.
119.
IversenR, AndersenPA, JensenKS, WintherJR, SigurskjoldBW. Thiol-disulfide exchange between glutaredoxin and glutathione. Biochemistry, 49:810–820. 2010.
120.
IzziV, ChiurchiùV, D'AquilioF, PalumboC, TresoldiI, ModestiA, BaldiniPM. Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophages. Int J Oncol, 34:543–550. 2009.
121.
JacksonSH, DevadasS, KwonJ, PintoLA, WilliamsMS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol, 5:818–827. 2004.
122.
JacobC. A scent of therapy: pharmacological implications of natural products containing redox-active sulfur atoms. Nat Prod Rep, 23:851–863. 2006.
123.
JacobC, WynyardPG. Redox Signaling and Regulation in Biology and Medicine (Edn)Weinheim, Germany: Wiley WCH, 2009.
124.
JankovicJ. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry, 79:368–376. 2008.
125.
JanssenYM, MatalonS, MossmanBT. Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. Am J Physiol Lung Cell Mol Physiol, 273:L789–L796. 1997.
126.
JensenC, ClausenJ. Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis–effects of antioxidant supplementation. Acta Pharmacol Toxicol, 59:S450–S453. 1986.
127.
KaganV, SerbinovaE, PackerL. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem Biophys Res Commun, 169:851–857. 1990.
128.
KanetoH, KajimotoY, FujitaniY, MatsuokaT, SakamotoK, MatsuhisaM, YamasakiY, HoriM. Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction. Diabetologia, 42:1093–1097. 1999.
129.
KapposL, GoldR, MillerDH, MacmanusDG, HavrdovaE, LimmrothV, PolmanCH, SchmiererK, YousryTA, YangM, EraksoyM, MeluzinovaE, RektorI, DawsonK T, SandrockAW, O'NeillGN. Efficacy and safety of oral fumarate in patients with relapsing remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet, 372:1463–1472. 2008.
130.
KargE, KlivenyiP, NemethRE, BenciskK, PintérS, VécseiL. Nonenzymatic antioxidants of blood in multiple sclerosis. J Neurol, 246:533–539. 1999.
131.
KaurD, YantiriF, RajagopalanS, KumarJ, MoJQ, BoonplueangR, ViswanathV, JacobsR, YangL, BealMF, Di-MonteD, VolitaskisI, EllerbyL, ChernyRA, BushAI, AndersenJK. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron, 37:899–909. 2003.
132.
KennedyAD, DeLeoFR. PI3K and NADPH oxidase: a class act. Blood, 112:4788–4789. 2008.
133.
KharaevaZ, GostovaE, De LucaC, RaskovicD, KorkinaL. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition, 25:295–302. 2009.
134.
KitaT, NaganoY, YokodeM, IshiiK, KumeN, OoshimaA, YoshidaH, KawaiC. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA, 84:5928–5931. 1987.
KlaunigJE, KamendulisLM. The role of oxidative stress in carcinogenesis. Ann Rev Pharm Toxicol, 44:239–267. 2004.
137.
KleinbongardP, DejamA, LauerT, JaxT, KerberS, GhariniP, BalzerJ, ZotzRB, ScharfRE, WillersR, SchechterAN, FeelishM, KelmM. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radical Bio Med, 40:295–302. 2006.
138.
KobayashiM, YamamotoM. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal, 7:385–394. 2005.
139.
KoenitzerJR, FreemanBA. Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease. Ann NY Acad Sci, 1203:45–52. 2010.
140.
Kretz-remiC, BateEE, ArrigoAP. Amino acid analogs activate NF-kB through redox-dependent IkB-a phosphorylation. Consequence on HIV-1 long terminal repeat activation. J Biol Chem, 273:3180–3191. 1998.
LamasS, MarsdenPA, LiGK, TempstP, MichelT. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA, 89:6348–6352. 1992.
145.
LambethJD. NOX Enzymes and the biology of reactive oxygen. Nat Rev Immunol, 4:181–189. 2004.
146.
LangemannH, KabierschA, NewcombeJ. Measurement of lowmolecular-weight antioxidants, uric acid, tyrosine and tryptophan in plagues and white matter from patients with multiple sclerosis. Eur Neurol, 32:248–252. 1992.
147.
LarssonR, CeruttiP. Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure in mouse epidermal cells to oxidants. Cancer Res, 49:5627–5632. 1989.
148.
LawlorMA, AlessiDR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?J Cell Sci, 114:2903–2910. 2001.
149.
LeeHP, ZhuX, CasadesusG, CastellaniRJ, NunomuraA, SmithMA, LeeHG, PerryG. Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev Neurother, 10:1201–1208. 2010.
LeiXG, ChengWH, McClungJP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr, 27:41–61. 2007.
152.
LeppertD, WaubantE, GalardyR, BunnettNW, HauserSL. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol, 154:4379–4389. 1995.
153.
LiH, FörstermannU. Nitric oxide in the pathogenesis of vascular disease. J Pathol, 190:244–254. 2000.
154.
LicastroF, CandoreG, LioD, PorcelliniE, Colonna-RomanoG, FranceschiC, CarusoC. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing, 2:8. 2005.
155.
Lih-BrodyL, PowellSR, CollierKP, ReddyGM, CerchiaR, KahnE, WeissmanGS, KatzS, FloydRA, McKinleyMJ, FisherSE, MullinGE. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci, 41:2078–2086. 1996.
156.
LimaES, Di MascioP, RubboH, AbdallaDS. Characterization of linoleic acid nitration in human blood plasma by mass spectrometry. Biochemistry, 41:10717–10722. 2002.
157.
LoftS, PoulsenHE. Cancer risk and oxidative DNA damage in man. J Mol Med, 74:297–312. 1996.
158.
LoveraJ, BagertB, SmootK, MorrisCD, FrankR, BogardusK, WildK, OkenB, WhithamR, BourdetteD. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Mult Scler, 13:376–385. 2007.
159.
LowesMA, BowcockAM, KruegerJG. Pathogenesis and therapy of psoriasis. Nature, 445:866–873. 2007.
160.
MaccarroneM, UllrichV. Redox regulation in disease and ageing. Cell Death Differ, 11:949–951. 2004.
161.
MaccarroneM, Manca di VillahermosaS, GiacominelliSR, Taccone-GallucciM. Vitamin E, 5-lipoxygenase and kidney disease. New Topics in Vitamin E Research. BellockOH. New York: Nova Science Publishers, 2007; 111–132.
162.
MaccarroneM, BrüneB. Redox regulation by ischemia/reperfusion. Cell Death Differ, 13:2002–2003. 2006.
163.
MaccarroneM, BruneB. Redox Regulation in acute and chronic inflammation. Cell Death Differ, 16:1184–1186. 2009.
164.
MaccarroneM, BariM, GasperiV, Demmig-AdamsB. The photoreceptor protector zeaxanthin induces cell death in neuroblastoma cells. Anticancer Res, 25:3871–3876. 2005.
165.
MaccarroneM, CataniMV, IraciS, MelinoG, Finazzi AgròA. A survey of reactive oxygen species and their role in dermatology. J Eur Acad Derm Vener, 8:185–202. 1997.
166.
MaccarroneM, MelinoG, Finazzi AgròA. Lipoxygenases and their involvement in programmed cell death. Cell Death Differ, 8:776–784. 2001.
167.
MaczurekA, ShanmugamK, MünchG. Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Ann N Y Acad Sci, 1126:147–151. 2008.
MaioliE, ValacchiG. Rottlerin: basis for a possible usage in psoriasis. Curr Drug Metab, 11:424–430. 2010.
170.
MalfroyB, DoctrowSR, OrrPL, ToccoG, FedoseyevaEV, BenichouG. Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. Cell Immunol, 177:62–68. 1997.
171.
MannaSK, ZhangHJ, YanT, OberelyLW, AggarwalBB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor kB and activated protein-1. J Biol Chem, 273:13245–13254. 1998.
172.
MantovaniA, RomeroP, PaluckaAK, MarincolaFM. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet, 371:771–783. 2008.
173.
MaretW, ValleeBL. Thiolate ligand in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA, 95:3478–3482. 1998.
174.
MarnettLJ. Lipid peroxidation—DNA damage by malondialdehyde. Mut Res Fund Mol Mech Mutagen, 424:83–95. 1999.
175.
MarnettLJ. Oxyradicals and DNA damage. Carcinogenesis, 21:361–370. 2000.
176.
MarracciGH, JonesRE, McKeonGP, BourdetteDN. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol, 13:104–114. 2002.
177.
MartinJB. Molecular basis of the neurodegenerative disorders. N Engl J Med, 340:1970–1980. 1999.
178.
MaziereC, AuclairM, Rose-RobertF, LeflonP, MaziereJC. Glucose-enriched medium enhances cell-mediated low density lipoproteinvperoxidation. FEBS Lett, 363:277–279. 1995.
179.
MilesAM, GrishamMB. Antioxidant properties of aminosalicylates. Methods Enzymol, 234:555–572. 1994.
180.
MillerFJ, GuttermanDD, RiosCD, HeistadDD, DavidsonBL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res, 82:1298–1305. 1998.
MoroniG, NovembrinoC, QuagliniS, De GiuseppeR, GallelliB, UvaV, MontanariV, MessaP, BamontiF. Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Lupus, 19:65–72. 2010.
183.
MorozLL, Wan NorbyS, CrouzLA, SweedlerJV, GilletteR, ClarksonRB. Non-enzymatic production of nitric oxide (NO) from NO synthase inhibitors. Biochem Biophys Res Commun, 253:571–575. 1998.
NabelEG. Cardiovascular disease. N Engl J Med, 349:60–72. 2003.
186.
NakamuraH, NakamuraK, YodoiJ. Redox regulation of cellular activation. Annu Rev Immunol, 15:351–369. 1997.
187.
NakamuraK, HoriT, SatoN, SugieK, KawakamiT, YodoiJ. Redox regulation of a Src family protein tyrosine kinase p56lck in T cells. Oncogene, 8:3133–3139. 1993.
188.
NauseefWM. Biological roles for the NOX family NADPH oxidases. J Biol Chem, 283:16961–16965. 2008.
189.
NicollsMR, HaskinsK, FloresSC. Oxidants stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal, 9:879–889. 2007.
190.
NiwaY, SomiyaK, MichelsonAM, PugetK. Effect of liposomalencapsulated superoxide dismutase on active oxygenrelated human disorders. A preliminary study. Free Rad Res Commun, 1:137–153. 1985.
191.
NoseworthyJH, LucchinettiC, RodriguezM, WeinshenkerBG. Multiple sclerosis. N Eng J Med, 343:938–952. 2000.
192.
O'BrianCA, ChuF. Review: post-translational disulfide modifications in cell signaling: role of inter-protein, intra-protein, Sglutathionyl, and S-cysteaminyl disulfide modifications in signal transmission. Free Radic Res, 39:471–480. 2005.
OlofssonP, HolmbergJ, TordssonJ, LuS, AkerstromB, HolmdahlR. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet, 33:25–32. 2003.
OteizaPI, UchitelOD, CarrasquedoF, DuborovskiAL, RomaJC, FragaCG. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res, 22:535–539. 1997.
197.
PadayattyS, KatzA, WangY, EckP, KwonO, LeeJ, ChenS, CorpeC, DuttaA, DuttaS, LevineM. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr, 22:18–35. 2003.
198.
PalmerRMJ, ReesDD, AshtonDS, MoncadaS. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium dependent relaxation. Biochem Biophys Res Commun, 153:1251–1256. 1998.
199.
PappertEJ, TangneyCC, GoetzCG, LingZD, LiptonJW, StebbinsGT, CarneyPM. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose response study and correlations with plasma levels. Neurology, 47:1037–1042. 1996.
200.
ParolaM, BellomoG, RobinoG, BarreraG, DianzaniMU. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxidant Redox Signal, 1:255–284. 1999.
201.
PerkinsND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol, 8:49–62. 2007.
202.
PetersenSV, OuryTD, ValnickovaZ, ThøgersenIB, HøjrupP, CrapoJD, EnghildJJ. The dual nature of human extracellular superoxide dismutase: one sequence and two structures. Proc Natl Acad Sci USA, 100:13875–13880. 2003.
203.
PetersonJD, HerzenbergLA, VasquezK, WaltenbaughC. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA, 95:3071–3076. 1998.
204.
PokeFS, QadiA, HollowayAF. Reversing aberrant methylation patterns in cancer. Curr Med Chem, 17:1246–1254. 2010.
205.
PryorWA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med, 28:141–164. 2000.
206.
PryorWA, StahlW, RockCL. Beta carotene: from biochemistry to clinical trials. Nutr Rev, 58:39–53. 2000.
207.
QuerfurthHW, LaFerlaFM. Alzheimer's disease. N Engl J Med, 362:329–344. 2010.
208.
RadiR, BeckmanJS, BushK M, FreemanBA. Peroxynitrite oxidation of sulfhydryls. J Biol Chem, 266:4244–4250. 1991.
RahmanI, AdcockIM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J, 28:219–242. 2006.
211.
RahmanI, MacNeeW. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol, 277:L1067–L1088. 1999.
212.
RahmanI, MacNeeW. Role of oxidants/antioxidants in smoking-induced airways diseases. Free Rad Biol Med, 21:669–681. 1996.
213.
RahmanI, BauterMR, MejaK, KirkhamP. Curcumin restores glucocorticoid function and inhibits cigarette smoke-mediated IL-8 release in oxidant stressed monocytic U937 cell. Am J Respir Crit Care Med, 2:A395. 2005.
214.
RahmanI, MarwickJ, KirkhamP. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol, 68:1255–1267. 2004.
215.
RahmanI, Van SchadewijkAA, CrowtherAJ, HiemstraPS, StolkJ, MacNeeW, De BoerWI. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product is elevated in lungs of patients with chronic obstructive pulmonary disease (COPD)Am J Respir Crit Care Med, 166:490–495. 2002.
216.
RahmanI. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys, 43:167–188. 2005.
217.
RaoAV, RaoLG. Carotenoids and human health. Pharmacol Res, 55:207–216. 2007.
RapolaJM, VirtamoJ, RipattiS, HuttunenJK, AlbanesD, TaylorPR, HeinonenOP. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet, 349:1715–1720. 1997.
220.
ReevesEP, NaglM, Godovac-ZimmermannJ, SegalAW. Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte. J Med Microbiol, 52:643–651. 2003.
221.
RemansPH, WijbrandtsCA, SandersME, ToesRE, BreedveldFC, TakPP, van LaarJM, ReedquistKA. CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells. Arthritis Rheum, 54:3135–3143. 2006.
222.
RoscaMG, MustataTG, KinterMT, OzdemirAM, KernTS, SzwedaLI, BrownleeM, MonnierWM, WeissMF. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol, 289:F420–F430. 2005.
RossR. Atherosclerosis—an inflammatory disease. N Engl J Med, 340:115–126. 1999.
225.
RudolphTK, FreemanBA. Transduction of redox signaling by elecrophile-protein reactions. Sci Signal, 2:re7. 2009.
226.
RudolphV, RudolphTK, SchopferFJ, BonacciG, WoodcockSR, ColeMP, BakerPR, RamaniR, FreemanBA. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc Res, 85:155–166. 2009.
SalveminiD, RileyDP, CuzzocreaS. SOD mimetics are coming of age. Nat Rev Drug Disc, 1:367–374. 2002.
229.
SandstromPA, MannieMD, ButtkeTM. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J Leukoc Biol, 55:221–226. 1994.
230.
SchievenGL, MittlerRS, NadlerSG, KiriharaJM, BolenJB, KannerSB, LedbetterJA. ZAP-70 tyrosine kinase, CD45, and T cell receptor involvement in UV- and H2O2-induced T cell signal transduction. J Biol Chem, 269:20718–20726. 1994.
231.
SchmidE, Hotz-WagenblattA, HackV, DrogeW. Phosphorylation of the insulin receptor kinase by phosphocreatine in combination with hydrogen peroxide. The structural basis of redox priming. FASEB J, 13:1491–1500. 1999.
232.
SchoonbroodtS, FerreiraV, Best-BelpommeM, BoelaertJR, Legrand-PoelsS, KornerM, PietteJ. Crucial role of the aminoterminal tyrosine residue 42 and the carboxyl-terminal PEST domain of IkBa in NF-kB activation by an oxidative stress. J Immunol, 164:4292–4300. 2000.
233.
SchopferFJ, BakerPRS, FreemanBA. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?Trends Biochem Sci, 28:646–654. 2003.
234.
SchuppanD, JunkerY, BarisaniD. Celiac disease: from pathogenesis to novel therapies. Gastroenterology, 137:1912–1933. 2009.
235.
ScottGS, SpitsinSV, KeanRB, MikheevaT, KoprowskiH, HooperDC. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci USA, 99:16303–16308. 2002.
236.
ScottS, KranzJE, ColeJ, LincecumJM, ThompsonK, KellyN, BostromA, TheodossJ, Al–NakhalaBM, VieiraFG, RamasubbuJ, HeywoodJA. Design of studies in the standard murine model of ALS. Amyotroph Lateral Scler, 9:4–15. 2008.
237.
SechiG, DeleddaMG, BuaG, SattaW, DeianaGA, PesG, RosatiG. Reduced intravenous glutathione in the treatment of early Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry, 20:1159–1170. 1996.
238.
SevanianA, NordenbrandK, KimE, ErnesterL, HochsteinP. Microsomal lipid peroxidation: the role of NADPH-cytochrome P450 reductase and cytochrome P450. Free Radic Biol Med, 8:145–152. 1990.
239.
ShahD, KiranR, WanchuA, BhatnagarA. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol Lett, 129:7–12. 2010.
240.
ShibataN, HiranoA, KobayashiA, SasakiS, KatoT, matsumotoS, ShiozawaZ, KomoriT, IkemotoA, UmaharaT. Cu/Zn SOD like immune reactivity in Lewy body-like inclusions of sporadic ALS. Neurosci Lett, 179:149–152. 1994.
ShultsCW, OakesD, KieburtzK, BealMF, HaasR, PlumbS, JuncosJL, NuttJ, ShoulsonI, CarterJ, KompolitiK, PerlmutterJS, ReichS, SternM, WattsRL, KurlanR, MolhoE, HarrisonM, LewM. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol, 59:1541–1550. 2002.
243.
SkulachevVP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett, 423:275–280. 1998.
244.
SlaterAF, StefanC, NovelI, Van Den DobbelsteenDJ, OrreniusS. Signalling mechanisms and oxidative stress in apoptosis. Toxicol Lett, 82–83:149–153. 1995.
SpitellerP, SpitellerG. Strong dependence of the lipid peroxidation product spectrum whether Fe2+/O2 or Fe3+/O2 is used as oxidant. Biochim Biophys Acta, 1392:23–40. 1998.
247.
St. ClairEW, PisetskyDS, HaynesBF. Rheumatoid Arthritis, 1st. Philadelphia: Lippincott Williams & Wilkins, 2004.
248.
StamlerJS, SingleD, LoscalzoJ. Biochemistry of nitric oxide and its redox-activated forms. Science, 258:1898–1902. 1992.
249.
StaziAV, TrintiB. Selenium deficiency in celiac disease: risk of autoimmune thyroid diseases. Minerva Med, 99:643–653. 2008.
250.
StinissenP, RausJ, ZhangJ. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Critic Rev Immunol, 17:33–75. 1997.
251.
StockerR, KeaneyJFJr. Role of oxidative modifications in atherosclerosis. Physiol Rev, 84:1381–1478. 2004.
252.
StojiljkovićV, TodorovićA, PejićS, KasapovićJ, SaicićZS, RadlovićN, PajovićSB. Antioxidant status and lipid peroxidation in small intestinal mucosa of children with celiac disease. Clin Biochem, 42:1431–1437. 2009.
SunJ, SteenbergenC, MurphyE. S-Nitrosylation: no-related redox signaling to protect against oxidative stress. Antioxid Redox Signal, 8:1693–1705. 2006.
255.
SuwannarojS, LagooA, KeislerD, McMurrayRW. Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE)Lupus, 10:258–265. 2001.
SyburraC, PassiS. Oxidative stress in patients with multiple sclerosis. Ukr Biokhim Zh, 71:112–115. 1999.
258.
SzaboC, IschiropoulosH, RadiR. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov, 6:662–680. 2007.
259.
Taccone-GallucciM, Manca di VillahermosaS, MaccarroneM. Leukotrienes. N. Engl J Med, 358:746. 2008.
260.
TalpurR, CoxK, DuvicM. Efficacy and safety of topical tazarotene: a review. Expert Opin Drug Metab Toxicol, 5:195–210. 2009.
261.
TaupinP. A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease. Cent Nerv Syst Agents Med Chem, 10:16–21. 2010.
262.
TestST, WeissSJ. Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. J Biol Chem, 259:399–405. 1984.
263.
TewthanomK, JanwitayanujitS, TotemchockcyakarnK, Panomvana Na AyudhyaD. The effect of high dose of N-acetylcysteine in lupus nephritis: a case report and literature review. J Clin Pharm Ther, 35:483–485. 2010.
264.
ThomasJA, PolandB, HonzatkoR. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys, 319:1–9. 1995.
265.
ThompsonLM. Neurodegeneration: a question of balance. Nature, 452:707–708. 2008.
266.
TogashiH, SakumaI, YoshiokaM, KobayashiT, YasudaH, KitabatakeA, SaitoH, GrossSS, LeviR. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther, 262:343–347. 1992.
TrifunovicA, LarssonNG. Mitochondrial dysfunction as a cause of aging. J Intern Med, 263:167–178. 2008.
269.
UchidaK, ShiraishiM, NaitoY, ToriiN, NakamuraY, OsawaT. Activation of stress signaling pathways by the end product of lipid peroxidation. J Biol Chem, 274:2234–2242. 1999.
270.
UndurtiND. Is pyruvate and endogenous anti-inflammatory molecule?Nutrition, 22:965–972. 2006.
271.
ValkoM, LeibfritzD, MoncolJ, CroninMT, MazurM, TelserJ. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 39:44–84. 2006.
272.
ValkoM, RhodesCJ, MoncolJ, IzakovicM, MazurM. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 160:1–40. 2006.
273.
Van AckerSA, van den BergDJ, TrompMN, GriffioenDH, van BennekomWP, van der VijghWJ, BastA. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med, 20:331–342. 1996.
274.
VanderJagtDJ, HarrisonJM, RatliffDM, HunsakerLA, Vander JagtDL. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem, 34:265–270. 2001.
275.
VassortG, TuranB. Protective role of antioxidants in diabetes-induced cardiac dysfunction. Cardiovasc Toxicol, 10:73–86. 2010.
276.
VitaJA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr, 81:292S–297S. 2005.
277.
VladimirovaO, O'ConnorJ, CahillA, AlderH, ButunoiC, KalmanB. Oxygen damage to DNA in plaques of MS brains. Mult Scler, 4:413–418. 1998.
278.
VythA, TimnerJG, BossyutPMM, LouwerseES, Vianney De JongJMB. Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants. J Neurol Sci, 139:199–203. 1996.
279.
WangG, PierangeliSS, PapalardoE, AnsariGA, KhanMF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum, 62:2064–2072. 2010.
280.
WilkinsS, MastersCL, BushAI, ChernyRA, FinkelsteinDI. Cliquinol protects against cell death in Parkinson's disease models in vivo and in vitro. Advances in Behavioral Biology. IBAGS IX. GroenewegenH. New York: Springer, 2008.
WolffSP. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull, 49:642–652. 1993.
283.
WondrakGT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal, 11:3013–3069. 2009.
284.
WoodZ, SchröderE, Robin HarrisJ, PooleL. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci, 28:32–40. 2003.
285.
WoźniakA, DrewaG, Krzyzyńska-MaliniowskaE, CzajkowskiR, Protas-DrozdF, Mila-KierzenkowskaC, RozwodowskaM, SopońskaM, Czarnecka-ZabaE. Oxidant-antioxidant balance in patients with psoriasis. Med Sci Monit, 13:CR30–CR33. 2007.
286.
WuDC, ReDB, NagaiM, IschiropoulosH, PrzedborskiS. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci USA, 103:12132–12137. 2006.
287.
XavierRJ, PodolskyDK. Unravelling the pathogenesis of inflammatory bowel disease. Nature, 448:427–434. 2007.
288.
XieQW, ChoHJ, CalaycayJ, MumfordRA, SwiderekKM, LeeTD, DingA, TrosoT, NathanC. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 256:225–228. 1992.
289.
YadavV, BourdetteD. Oral disease-modifying therapies for multiple sclerosis: are we there yet?Curr Neurol Neurosci Rep, 10:333–335. 2010.
290.
YangL, CalingasanNY, WilleEJ, CormierK, SmithK, FerranteRJ, BealMF. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. J Neurochem, 109:1427–1439. 2009.
291.
YaoH, YangSR, KodeA, RajendrasozhanS, CaitoS, AdenugaD, HenryR, EdirisingheI, RahmanI. Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. Biochem Soc Trans, 35:1151–1155. 2007.
Zanotto-FilhoA, SchröderR, MoreiraJC. Xanthine oxidase-dependent ROS production mediates vitamin A pro-oxidant effects in cultured sertoli cells. Free Radic Res, 42:593–601. 2008.
294.
ZhangQ, YeDQ, ChenGP. Study on the relationship between protein oxidation and disease activity in systemic lupus erythematosus. Zhonghua Liu Xing Bing Xue Za Zhi, 29:181–184. 2008.
295.
ZhangY. Allyl isothiocyanate as a cancer chemopreventive phytochemical. Mol Nutr Food Res, 54:127–135. 2010.
296.
ZhouQ, MrowietzU, Rostami-YazdiM. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med, 47:891–905. 2009.
297.
ZhuX, RainaAK, LeeHG, CasadesusG, SmithMA. Perry G Oxidative stress signalling in Alzheimer's disease. Brain Res, 1000:32–39. 2004.
298.
ZiouzenkovaO, GiesegSP, RamosP, EsterbauerH. Factors affecting resistance of low density lipoproteins to oxidation. Lipids, 31:S71–S76. 1996.
299.
ZuoY, XiangB, YangJ, SunX, WangY, CangH, YiJ. Oxidative modification of caspase-9 facilitates its activation via disulfide-mediated interaction with Apaf-1. Cell Res, 19:449–457. 2009.
300.
ZwerschkeW, MazurekS, StöcklP, HütterE, EigenbrodtE, Jansen-DürrP. Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. Biochem J, 376:403–411. 2003.
